Partners

Gilead Sciences

Gilead Sciences is a biopharmaceutical company focused on researching, developing and commercializing innovative drugs. They are best known for their work in antiviral drugs, particularly for the treatment of HIV/AIDS and hepatitis. They are also active in oncology and inflammatory diseases.

Pink Ribbon is happy to partner with a pharmaceutical company that invests in drugs for women with advanced, triple-negative breast cancer, such as Gilead Sciences. Gilead brought to market a promising drug that improves survival for women with metastatic breast cancer who do not benefit from hormone therapy compared to conventional chemotherapy.

The company is not only setting its sights on drug development for this lesser-known breast cancer, but is also making available an information platform* for patients. This online platform, available in three languages, contains accessible information and testimonials about triple-negative breast cancer, a disease that affects more younger women.

And because of their expertise in this, on their initiative we organized two patient days for triple-negative breast cancer patients with interesting speakers, applied to what these women experience. We were also allowed to create five testimonials with them:  

Els has been living with breast cancer for more than 20 years. Since 2022, there have been metastases in her peritoneum. She tries to live mostly in the now.

"Cancer is part of my daily life. I live more today and tomorrow."

Denise was diagnosed with triple negative breast cancer in 2020, fortunately at an early stage. So far, everything remains stable.

"It went from, 'oh, that's not so bad' to 'oy, this is really serious' anyway."

Jeannin has been living with breast cancer for 9 years and metastases for 5 years. She draws strength from her love of flower arranging and remains positive despite the constant threat of relapse.

"You can always be in a relapse, but I try to push that away from me."

Christelle was diagnosed with triple negative breast cancer when she was 34. At 40, the cancer returned, but after treatment, she is again in remission.

"Théo looked at me and said, 'Mommy, are you sick?' He had understood without us having to say it."

Irène was diagnosed with breast cancer in 2011. Ten years later, a lung metastasis occurred. But she does not sit still.‍‍

"I forgot about my cancer and thought, I'm not going to die because I'm moving," he said.
Learn more:
Gilead Sciences

Related articles

No articles were found with this project.
View all our articles here.
How can you help?